Our Story
BrainLove began with a simple observation: people facing concerns about memory, thinking, and brain health for themselves or a loved one often feel lost long before they ever receive a diagnosis.
Over more than twenty years caring for individuals and families affected by Alzheimer's disease and other conditions of brain aging, Dr. Dani Cabral saw the same pattern again and again. Patients struggled to access specialized care. Families were left to navigate complex decisions with little guidance. Important questions went unanswered. Even when a diagnosis was made, many people were left wondering what came next.
But brain aging is not a single moment. It is a journey that unfolds over years. The most meaningful care doesn't come from a report, a test result, or a single appointment. It comes from trusted relationships, honest conversations, and a plan that evolves as life changes.
BrainLove is not simply offering neurology services. We provide a fundamentally different care experience, one that combines expert medical care with education, guidance, and ongoing support for both individuals and the people who love them. Our goal is always to provide clarity, direction, and hope grounded in science.
Our Mission
We provide a fundamentally different model of physician-led brain health care that combines precision medicine, personalized guidance, continuous support, and community to transform how individuals and families navigate memory loss, Alzheimer’s disease, cognitive change, and the future of brain aging.
Our Vision
A world where every person facing concerns about brain health has access to the knowledge, relationships, and support needed to live with purpose, possibility, and hope.
Our Founder
Dr. Danielle “Dani” Cabral is an Ivy-league trained, internationally respected Alzheimer’s specialist neurologist and psychiatrist with over 15 years of experience in Alzheimer’s care and clinical research. She’s known for her unique ability to translate cutting-edge science into real-world, deeply human care. Dr. Cabral has served as principal investigator for multiple Alzheimer’s clinical trials, received grants to advance access and awareness, and speaks widely on transforming brain aging and care.
Academics and Certifications
- BA, International Studies, Vassar College
- Post-Baccalaureate Pre-Medical Studies, Harvard University
- MD, University of Arizona College of Medicine-Phoenix
- Combined Neurology & Psychiatry Residency; Neurodegenerative Disease Research Fellowship, Brown University
- Board-Certified in Neurology, American Board of Psychiatry & Neurology, 2017
- Board-Certified in Psychiatry, American Board of Psychiatry & Neurology, 2018
- Arizona Medical License: 2018-Present
- Assistant Professor, Departments of Neurology and Psychiatry, University of Arizona College of Medicine 2018-present
Clinical Trials and Research Experience
- Principal Investigator for numerous Alzheimer’s clinical trials, including those studying lecanemab, donanemab, aducanumab, semaglutide, and gantenerumab
- Associate Principal Investigator, Alzheimer’s Clinical Trials Consortium (ACTC) 2018-2023
- Research Member, Arizona Psilocybin Research Advisory Council, 2023-2026
- Grants and Awards received from:
- Alzheimer’s Association and Alzheimer’s Therapeutics Research Institute
- National Institutes of Health
- National Institute of Mental Health
- Arizona Alzheimer’s Consortium
- American Academy of Neurology
